US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Accor (AC) 銘柄情報

Accor (AC)

47.39

2.52

(5.62%)

終了 6月13日 12:30AM

Accor (AC) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

47.39

( 5.62% )

買値

46.00

売値

47.50

出来高

997,147

46.00 日の範囲 47.52

37.54 52 週間の範囲 50.34

時価総額

前日終値

44.87

始値

46.00

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,015,058 €

発行済株式数

224,943,620

配当利回り

1.35 (3.05%)

PER

28.22

1 株当たり利益 (EPS)

1.61

歳入

5.64B

純利益

449M

Accor SA operates a chain of hotels worldwide. The company operates through Premium, Midscale and Economy; and Luxury & Lifestyle segments. Its Premium, Midscale and Economy segment includes the Ibis, Novotel, Mercure, Swissôtel, Mövenpick, and Pullman brands operating in Europe and North Africa, th... Accor SA operates a chain of hotels worldwide. The company operates through Premium, Midscale and Economy; and Luxury & Lifestyle segments. Its Premium, Midscale and Economy segment includes the Ibis, Novotel, Mercure, Swissôtel, Mövenpick, and Pullman brands operating in Europe and North Africa, the Middle East, Africa, the Asia-Pacific, the Americas, and China. The company Luxury & Lifestyle segment includes the Raffles and Fairmont, Sofitel, MGallery and Emblems, and Ennismore brands. It also owns, leases, manages, and franchises hotels. In addition, the company provides discount card programs; catering and event management; digital, hotel booking, and concierge services; and other services in events, fine dining, and entertainment, as well as operation of performance venues and coworking spaces. Further, it offers hotel management, personnel, procurement, treasury and management, IT, advertising, and other advice services. Accor SA was incorporated in 1960 and is headquartered in Issy-les-Moulineaux, France. 詳細を表示

セクター

Consumer Discretionary

業界

Hotels, Lodging & Leisure

ウェブサイト

group.accor.com

本社

Issy-les-moulineaux, France

設立

1960

Accor is listed in the Consumer Discretionary sector of the ユーロネクスト with ticker AC. The last closing price for Accor was 44.87 €. Over the last year, Accor shares have traded in a share price range of 37.54 € to 50.34 €.

Accor currently has 224,943,620 shares in issue. The market capitalisation of Accor is 10.66 € billion. Accor has a price to earnings ratio (PE ratio) of 28.22.

CLSA and Sanford Bernstein Sign Equity Research Cooperation Agreement

CLSA and Sanford Bernstein Sign Equity Research Cooperation Agreement HONG KONG, June 8 /PRNewswire/ -- Two of the world's leading equity...

Lew Sanders, CEO of Alliance Capital, to Present at Merrill Lynch Investor Conference

Lew Sanders, CEO of Alliance Capital, to Present at Merrill Lynch Investor Conference NEW YORK, Nov. 8 /PRNewswire-FirstCall/ -- Lewis A...

Thomas Wright Joins Sanford C. Bernstein as Head of Global Trading

Thomas Wright Joins Sanford C. Bernstein as Head of Global Trading NEW YORK, Aug. 10 /PRNewswire/ -- Sanford C. Bernstein & Co., LLC...

Lew Sanders, CEO of Alliance Capital, to Present at Merrill Lynch Investor Conference

Lew Sanders, CEO of Alliance Capital, to Present at Merrill Lynch Investor Conference NEW YORK, Nov. 18 /PRNewswire-FirstCall/ -- Lewis A...

Alliance Capital Management Provides Update On Short Term Trading Investigation

Alliance Capital Management Provides Update On Short Term Trading Investigation NEW YORK, Nov. 6 /PRNewswire-FirstCall/ -- As previously...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	1.6	3.4942127102	45.79	47.52	44.51	808138	45.26069262	DE
4	3.39	7.70454545455	44	48.05	42.53	781872	45.23220368	DE
12	7.38	18.4453886528	40.01	48.05	38.56	956114	43.59964212	DE
26	0.42	0.894187779434	46.97	50.28	37.54	907787	44.57541037	DE
52	2.27	5.03102836879	45.12	50.34	37.54	785991	44.42926701	DE
156	14.66	44.7907118851	32.73	51.1	27.71	720532	40.73563472	DE
260	12.36	35.2840422495	35.03	51.1	20.47	730925	35.64465496	DE

AC - Frequently Asked Questions (FAQ)

What is the current Accor share price?

The current share price of Accor is 47.39 €

How many Accor shares are in issue?

Accor has 224,943,620 shares in issue

What is the market cap of Accor?

The market capitalisation of Accor is EUR 10.66B

What is the 1 year trading range for Accor share price?

Accor has traded in the range of 37.54 € to 50.34 € during the past year

What is the PE ratio of Accor?

The price to earnings ratio of Accor is 28.22

What is the cash to sales ratio of Accor?

The cash to sales ratio of Accor is 1.81

What is the registered address of Accor?

The registered address for Accor is 82, rue Henri-Farman, Issy-les-Moulineaux, Ile-de-France, 92130

What is the Accor website address?

The website address for Accor is group.accor.com/en

Which industry sector does Accor operate in?

Accor operates in the Hotels, Lodging & Leisure sector

jour_trader

jour_trader 3分前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 7分前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 10分前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

mmayr

Complete Meltdown is Coming

https://youtu.be/5sp1minxEns?is=-W1we0evirBu6yX9

boston127

boston127 17分前

Something good is happening here.

I'm not dumping, just trying to sell high and buy low.

shajandr

shajandr 18分前

As you've nott replied to my questions (perhaps you, like many/most others have me on Ignore), infra, prolly in view of there being no meritorious argument supporting the SEC's so-kalt 'gag rule' on settlements, I've restructured my inquiry. I'd still enjoy reading your reply to the original questio

janice shell

janice shell 18分前

I'll bet you can even get ivermectin at Amazon now. You can get everything at Amazon.

Damn, should I get this? It's tempting. Fantastic price:

https://investorshub.advfn.com/uimage/uploads/2026/6/13/vujmmimage.jpeg

https://www.amazon.com/EDGING-CASTING-En

bim524

bim524 19分前

Maybe you should go to an Amazon board and complain over there Instead of spreading this nonsense about a fake agreement here. If you even had any semblance of historical fact you would pretend to know that this company won’t even name companies in their PRs… if they issue a statement that says ther

Just give me $1.50

Just give me $1.50 20分前

Huh?

You haven't been watching and/or listening to the news?

Because of peace talks failing, and the War in Iran restarting, Elite submitted a waiver request to the SEC to have their 10-K filing deadline pushed back by two weeks due to safety concerns.

It

HyGro

No biotech passes on the chance for an FDA approval -- NWBO sure did and likely because FDA told them not to bother. No oncology drug can be very profitable with out U.S. approval. NWBO didn't even try. Why, because they knew they wouldn't get accepted. Just watch, NWBO won't apply for FDA

grantastic

grantastic 22分前

It is crazy to believe that HDUP is pursuing any legitimate business deals.

Especially after Mark Hutchison scrubbed all mention of HDUP from his professional profile. He's moved on from the scam. Shareholders need to move on too.

The only evidence ever shown of these

sandor8

sandor8 22分前

It is only proving to itself to be part of the group of psychopath an sociopath world over known today, only needing a driver of a tank to hint physically to them that our essence can be flattened, quite simplifying and ameliorating the other's existence.

normal investor

normal investor 26分前

Just give me $1.50

Just give me $1.50 26分前

LMAO.

1-2 years?

You mean 1-2 ............. WEEKS?

Shareholder: "Is the timeline for uplisting to NASDAQ or acquisition merger still on track to be around August 2026?"

Nasrat: "NO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!"

nowwhat2

nowwhat2 31分前

https://investorshub.advfn.com/uimage/uploads/2026/6/13/kgwzibtc_june_12_zoom_cup_depend.jpghttps://investorshub.advfn.com/uimage/uploads/2026/6/13/wvapvdepend_sikh.jpg

.

mrwrn2010

mrwrn2010 34分前

What I’m reading seems to indicate that Elite is still not prevented from obtaining *tentative approval* from the FDA on the OxyContin ANDA, only that they can’t get final approval until/after 8/24/27. I believe Nasrat also confirmed this last call. Ideally, we see a tentative Oxy approval sometime

Just give me $1.50

Just give me $1.50 36分前

***** I just paid for the new documents *****

Friday, June 12, 2026

STIPULATION AND ORDER REGARDING IRREVOCABLE COVENANT NOT TO COME TO MARKET AND DISMISSAL. Signed by Judge Karen M. Williams on 6/12/2026.

3331

The premise is clear: the most lucrative investments are the ones made before the rest of the world catches on. IT'S NO SECRET, THE KEY IS TO GET IN EARLY!

The SpaceX IPO created 4,400 millionaires in minutes, and over 400 people made over $100 Million, despite never turning a pr

WATERFALL1

WATERFALL1 39分前

Agreed

We are facing reversal to North direction

Patience is needed

WATERFALL1

WATERFALL1 40分前

Do you want to kidding us with your opinion ?

grantastic

grantastic 42分前

I'm not here to "help" scammers that make bogus claims.

In hindsight, most of my APRU takes were proven accurate. Were they "helpful" to anyone? I can hope so, but I have no idea if I actually saved anyone from the idiotic mistake of thinking APRU was a legitimate enterprise.

Genz2

A trillionaire….. That’s something to aspire to and be proud of!!!

NYATC

I’d like to think that is the case as well but why not put out a post or something to keep people in the loop

Cuprina Holdings Cayman

Fundo Invests Setoriais ...

Dolby Laboratories

BNP PARIBAS ISSUANCE

Eqty Lkd Nts 09/08/27

XS2891684941 20280929 62...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。